These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 21425426

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.
    Fan JG.
    J Dig Dis; 2008 May; 9(2):63-7. PubMed ID: 18419637
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know.
    Akbar DH, Kawther AH.
    Med Sci Monit; 2006 Jan; 12(1):RA23-6. PubMed ID: 16369477
    [Abstract] [Full Text] [Related]

  • 26. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course.
    Cortez-Pinto H, Camilo ME.
    Best Pract Res Clin Gastroenterol; 2004 Dec; 18(6):1089-104. PubMed ID: 15561640
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Non-Alcoholic Fatty Liver Disease (NAFLD): new challenge for general practitioners and important burden for health authorities?
    Ahmed MH, Abu EO, Byrne CD.
    Prim Care Diabetes; 2010 Oct; 4(3):129-37. PubMed ID: 20299294
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G, Babini M.
    Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
    [Abstract] [Full Text] [Related]

  • 31. Lifestyle advice in non-alcoholic fatty liver disease.
    Manco M, Marcellini M, Nobili V.
    J Gastroenterol Hepatol; 2007 Apr; 22(4):604-5. PubMed ID: 17376064
    [No Abstract] [Full Text] [Related]

  • 32. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
    Sevastianos VA, Hadziyannis SJ.
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):59-79. PubMed ID: 19072371
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Management of metabolic syndrome in children and adolescents.
    Pacifico L, Anania C, Martino F, Poggiogalle E, Chiarelli F, Arca M, Chiesa C.
    Nutr Metab Cardiovasc Dis; 2011 Jun; 21(6):455-66. PubMed ID: 21565479
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic.
    Ismail MH.
    Am J Med Sci; 2011 Jun; 341(6):485-92. PubMed ID: 21412139
    [Abstract] [Full Text] [Related]

  • 39. Review of treatment options for nonalcoholic fatty liver disease.
    Corrado RL, Torres DM, Harrison SA.
    Med Clin North Am; 2014 Jan; 98(1):55-72. PubMed ID: 24266914
    [Abstract] [Full Text] [Related]

  • 40. Review article: diagnosis and treatment of non-alcoholic fatty liver disease.
    Oh MK, Winn J, Poordad F.
    Aliment Pharmacol Ther; 2008 Sep 01; 28(5):503-22. PubMed ID: 18532991
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.